Animal models of Pneumocystis pneumonia (PCP) have been used for the discovery of new antimicrobial agents (1, 2) and vaccine testing (3, 4) as well as understanding CD4+ T cell immunity in the lung (5–7). Here, CD4 is linked to pneumocystosis.